Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 2
1972 2
1973 2
1974 1
1978 2
1983 1
1985 1
1995 2
1996 6
1997 3
1998 2
1999 2
2000 6
2001 4
2002 4
2003 6
2004 1
2005 1
2006 3
2007 3
2008 4
2009 8
2010 7
2011 7
2012 6
2013 5
2014 12
2015 7
2016 9
2017 8
2018 5
2019 7
2020 8
2021 3
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

147 results
Results by year
Filters applied: . Clear all
Page 1
Flip the coin: IL-7 and IL-7R in health and disease.
Barata JT, Durum SK, Seddon B. Barata JT, et al. Among authors: seddon b. Nat Immunol. 2019 Dec;20(12):1584-1593. doi: 10.1038/s41590-019-0479-x. Epub 2019 Nov 19. Nat Immunol. 2019. PMID: 31745336 Review.
Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4+ T Cells.
Śledzińska A, Vila de Mucha M, Bergerhoff K, Hotblack A, Demane DF, Ghorani E, Akarca AU, Marzolini MAV, Solomon I, Vargas FA, Pule M, Ono M, Seddon B, Kassiotis G, Ariyan CE, Korn T, Marafioti T, Lord GM, Stauss H, Jenner RG, Peggs KS, Quezada SA. Śledzińska A, et al. Among authors: seddon b. Immunity. 2020 Jan 14;52(1):151-166.e6. doi: 10.1016/j.immuni.2019.12.007. Epub 2020 Jan 7. Immunity. 2020. PMID: 31924474 Free PMC article.
Radiotherapy for management of extremity soft tissue sarcomas: why, when, and where?
Haas RL, Delaney TF, O'Sullivan B, Keus RB, Le Pechoux C, Olmi P, Poulsen JP, Seddon B, Wang D. Haas RL, et al. Among authors: seddon b. Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):572-80. doi: 10.1016/j.ijrobp.2012.01.062. Epub 2012 Apr 18. Int J Radiat Oncol Biol Phys. 2012. PMID: 22520481 Review.
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.
Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, Krailo MD, Gebhardt M, Pápai Z, Meyer J, Nadel H, Randall RL, Deffenbaugh C, Nagarajan R, Brennan B, Letson GD, Teot LA, Goorin A, Baumhoer D, Kager L, Werner M, Lau CC, Sundby Hall K, Gelderblom H, Meyers P, Gorlick R, Windhager R, Helmke K, Eriksson M, Hoogerbrugge PM, Schomberg P, Tunn PU, Kühne T, Jürgens H, van den Berg H, Böhling T, Picton S, Renard M, Reichardt P, Gerss J, Butterfass-Bahloul T, Morris C, Hogendoorn PC, Seddon B, Calaminus G, Michelagnoli M, Dhooge C, Sydes MR, Bernstein M; EURAMOS-1 investigators. Bielack SS, et al. Among authors: seddon b. J Clin Oncol. 2015 Jul 10;33(20):2279-87. doi: 10.1200/JCO.2014.60.0734. Epub 2015 Jun 1. J Clin Oncol. 2015. PMID: 26033801 Free PMC article. Clinical Trial.
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial.
Seddon B, Strauss SJ, Whelan J, Leahy M, Woll PJ, Cowie F, Rothermundt C, Wood Z, Benson C, Ali N, Marples M, Veal GJ, Jamieson D, Küver K, Tirabosco R, Forsyth S, Nash S, Dehbi HM, Beare S. Seddon B, et al. Lancet Oncol. 2017 Oct;18(10):1397-1410. doi: 10.1016/S1470-2045(17)30622-8. Epub 2017 Sep 4. Lancet Oncol. 2017. PMID: 28882536 Free PMC article. Clinical Trial.
Management of osteosarcoma.
Whelan J, Seddon B, Perisoglou M. Whelan J, et al. Among authors: seddon b. Curr Treat Options Oncol. 2006 Nov;7(6):444-55. doi: 10.1007/s11864-006-0020-y. Curr Treat Options Oncol. 2006. PMID: 17032557 Review.
Experimental therapies in Ewing's sarcoma.
Windsor R, Strauss S, Seddon B, Whelan J. Windsor R, et al. Among authors: seddon b. Expert Opin Investig Drugs. 2009 Feb;18(2):143-59. doi: 10.1517/13543780802715784. Expert Opin Investig Drugs. 2009. PMID: 19236262 Review.
147 results